ImmunoMet Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ImmunoMet Therapeutics, Inc. - overview
Established
2015
Location
Houston, TX, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in Houston, Texas, ImmunoMet Therapeutics, Inc. operates as a biopharmaceutical company, developing anti-tumor and immuno-oncology therapies.
Current Investors
Mirae Asset Venture Investment, MetaVest, Aju Tech
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Specialty Pharmaceuticals
Website
www.immunomet.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
ImmunoMet Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.